Zydus’ generic of hormone therapy patch gets U.S. FDA nod
Zydus Lifesciences has received final approval from the U.S. Food and Drug Administration (FDA) for its abbreviated new drug application for Estradiol and Levonorgestrel Transdermal System, 0.045 mg/0.015 mg per day. Bayer’s Climara Pro Transdermal System 0.045 mg/0.015 mg per day is the reference listed drug for the product. Estradiol and Levonorgestrel Transdermal System, which…
Read More “Zydus’ generic of hormone therapy patch gets U.S. FDA nod” »